With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...
Means argued that the substantial cuts Kennedy has made to Health and Human Services, the National Institutes of Health, the ...
Calley Means joins Dasha Burns at a Politico health care summit to discuss HHS Secretary Robert F. Kennedy Jr.'s MAHA agenda. In this portion, he calls out food industry lobbyists for influencing the ...
Trump signs orders imposing 10% minimum tariff, broader reciprocal tariffs—but exemptions for pharma
President Donald Trump made good on his threat of announcing new and steeper tariffs during a Wednesday afternoon White House ...
Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in ...
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...
We purchased shares of Icon in March 2024 for ~$323.00 per share. Why did we sell our ICLR position and move on? Click here ...
Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity ...
Learn more about whether Jazz Pharmaceuticals plc or Novo Nordisk A/S is a better investment based on AAII's A+ Investor ...
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...
The Trump administration's proposal to cut National Institutes of Health (NIH) indirect funds has been widely attacked, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results